CAS 407582-47-2

Febuxostat metabolite 67M-2

CAS: 407582-47-2

Formula: C₁₆H₁₆N₂O₄S

Molecular weight: 332.38

Ref: 4Z-F-3933

Febuxostat 67M-2

Controlled Product

CAS: 407582-47-2

Applications Febuxostat 67M-2 is a derivative compound of Febuxostat 67M-1 (F229005) which is an inhibitor of xanthine oxidase. It reduces uric acid production in the body and also used to reduce the risk of gout or kidney stone formation.
References Du, J., et al.: Handbook of Metabolic Pathways of Xenobiotics, 4, 1395 (2014)

Formula: C₁₆H₁₆N₂O₄S

Color and Shape: Neat

Molecular weight: 332.37

Ref: TR-F229010

Febuxostat 67M-2

CAS: 407582-47-2

Febuxostat 67M-2 is a peptide that interacts with proteins. It has been shown to act as an inhibitor of the receptor for urokinase plasminogen activator (uPA). Febuxostat 67M-2 is used as a research tool in cell biology and pharmacology. This peptide has been shown to inhibit ion channels such as potassium channels and calcium channels, thereby interfering with cellular function. The chemical name for Febuxostat 67M-2 is N-[4-(1-methyl-1H-imidazol-5-yl)phenyl]-N′-[(3S)-3-(1,3,3,-trimethylbutyl)pentyl]urea monohydrochloride. CAS No. 407582-47-2

Formula: C₁₆H₁₆N₂O₄S

Purity: Min. 95%

Molecular weight: 332.4 g/mol

Ref: 3D-HRA58247

Febuxostat Impurity 41

CAS: 407582-47-2

Formula: C₁₆H₁₆N₂O₄S

Molecular weight: 332.37

Ref: ST-EA-CP-F7059

Febuxostat 67M-2

CAS: 407582-47-2

Febuxostat 67M-2, derived from 67M-1, inhibits xanthine oxidase, lowers uric acid, and prevents gout/kidney stones.

Formula: C₁₆H₁₆N₂O₄S

Color and Shape: Solid

Molecular weight: 332.37

Ref: TM-T69282